Biogen Shares Up 1.3%; Asian Publications Overnight Discussed 'Samsung Begins Talks with Biogen to secure control of biosimilar joint venture'; BZ NOTE: Biogen Announced Last Thurs. Commercialization Deal With Samsung Bioepis, AbbVie For IMRALDI
luke@benzinga.com